Chris Erickson

Director at Cime Therapeutics.

Denver, CO
Cime Therapeutics

Raised on Cime Therapeutics filings

$2.1M

of $2.5M offered across 1 Form D filing

Form D filings: 1
Teammates: 1
Last filing: Mar 21, 2025

Company

Cime Therapeutics

Biotech · Denver, CO

Shielded stem cells for blood disease transplants

Shielded stem cells for blood disease transplants

Investors: 3
Founded: 2024
Still open: $400K

Investors: 3
Sector: Biotech
Founded: 2024
HQ: Denver, CO

Cime Therapeutics filings

Cime Therapeutics Form D filings
Filed	Security	Sold of offered	Filing
Mar 21, 2025	Option to acquire	$2.1M/ $2.5M	Form D

Option to acquireFiled Mar 21, 2025Form D
$2.1M/ $2.5M

Works with

Also named on Cime Therapeutics filings

James Thomas Brewster IIChief Executive Officer, Form D signerForm D signer